Histoplasma Yeast Complement Fixation Antigen Dilute Ref# H30150 The fungal antigens and positiv...
FDA Device Recall #Z-2040-2016 — Class II — May 9, 2016
Recall Summary
| Recall Number | Z-2040-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 9, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Immuno-Mycologics, Inc |
| Location | Norman, OK |
| Product Type | Devices |
| Quantity | 467 units |
Product Description
Histoplasma Yeast Complement Fixation Antigen Dilute Ref# H30150 The fungal antigens and positive controls are used to detect antibodies in patient serum by the complement fixation (CF) procedure to aid in the diagnosis of four specific fungal diseases: Histoplasmosis, blastomycosis, coccidioidomycosis, and aspergillosis
Reason for Recall
The device was found to have bacterial contamination.
Distribution Pattern
Nationwide Distribution to UT, MA, OH, IN, NC, NY, VA, CA, IA and KY.
Lot / Code Information
Lot 111WH3
Other Recalls from Immuno-Mycologics, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1389-2025 | Class II | Candida ID Antigen, REAG, AG, REF C50110, Vol 1... | Feb 10, 2025 |
| Z-0545-2022 | Class II | CRYPTOCOCCAL ANTIGEN LATERAL FLOW ASSAY, IMMY, ... | Jan 3, 2022 |
| Z-2301-2020 | Class II | Histoplasma Immunodiffusion (ID) Antigen; The I... | Nov 4, 2019 |
| Z-2409-2018 | Class II | Cryptococcal Antigen Lateral Flow Assay (CrAg L... | Mar 30, 2018 |
| Z-1109-2017 | Class II | Cryptococcal Antigen Lateral Flow Assay (CrAg L... | Dec 27, 2016 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.